Tag: GSK

GSK Teamed Up with University of California to Advance Genomic Research

GlaxoSmithKline announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LG...

GSK Nucala Received Positive CHMP Opinion

GlaxoSmithKline announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending two new methods for administering ...

GSK Shingrix for the Prevention of Shingles Approved in China

GlaxoSmithKline plc announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or older. Shingrix i...

GSK Agreed to Sell Manufacturing Site in Cork

drug manufacturing
Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has entered into a definitive agreement to acquire a drug substance manufacturing site in Cork, Ireland, fro...

Mundipharma Appoints Former GSK Exec as Head of Market Access

The Mundipharma network of associated companies has appointed Jerome Moreau to the position of Head of Market Access, reporting to Chris Surridge, European Director of Strategy and Commercial Excellen...

GSK Q1 Sales Rose 5%

GlaxoSmithKline’s first-quarter sales rose 5 per cent after it benefited from the strong performance of its new shingles medicine and a novel two-drug regimen for the treatment of HIV. Total HIV dr...

Vectura Won Patent Case Against GlaxoSmithKline

British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7 million in damages fo...

GlaxoSmithKline and Neopharma Announce Partnership on UAE market

A new partnership between global healthcare company GlaxoSmithKline and UAE-based pharmaceutical firm Neopharma will localise production of high-demand medicine brands, speeding up supply to the UAE m...

GSK Invests $100M to Expand the Production Capacity

GSK today announced $100 million of new investment in its manufacturing site in Hamilton, Montana to expand the production capacity of key components of the adjuvant system used in several of GSK’s va...

CPI Partenrs with GSK and AZ to Create New Site

GSK, AstraZeneca, and GEA join resources to create a site in the UK for developing small-scale oral solid dosage APIs. CPI is collaborating with partners GSK and AstraZeneca to establish a bespoke,...

MMCC aims to catalyze transformational Change in Microbiology Testing

Attending Pharmig 2018, AstraZeneca's Karen Capper and GSK's Paul J Newby unveiled details of the Microbiology Modernisation Cross-industry Consortium (MMCC), an initiative that has been in the making...

GSK and Fimbrion Therapeutics unveiled a novel drug development candidate

Fimbrion Therapeutics announced that under its joint research collaboration with GSK, researchers have identified an orally available, small molecule development candidate.

GSK acquires promising biopharma company Tesaro

GlaxoSmithKline announced that it will acquire TESARO, an oncology-focused company for an aggregate cash consideration of approximately $5.1 billion.

GSK opens new manufacturing facility in Scotland

GSK launched a new £54 million ($70.3 million) production building to make APIs for Ellipta, a drug to treat chronic obstructive pulmonary disease.

GSK’s experimental TB vaccine shows promising results in clinical trials

GSK and Aeras reported that GSK’s M72/AS01E candidate vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults with latent tuberculosis infection.

GSK to close Stiefel Laboratories manufacturing faclility in Ireland

GlaxoSmithKline plans to close its dermatology subsidiary plant in Sligo (Ireland). The plant is to wind down, with final closure tabled for 2021.